⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001873088

Dion Gisele

Reports to the SEC for 2 companies · FREMONT, CA

Transactions

6

Companies

2

Filings

6

CIK

0001873088

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-16	IKTInhibikase Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-30	IKTInhibikase Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,667 sh	—	—	6,667
2023-06-14	CTKBCytek Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30.2K sh	—	—	30,242
2022-09-01	IKTInhibikase Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2022-06-01	CTKBCytek Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.8K sh	—	—	25,789
2021-07-22	CTKBCytek Biosciences, Inc.P Purchase	Director	PPurchase	+5,000 sh	$17.00	+$85K	5,000

Recent filings

6

Accepted (ET)
Jul 184
Dion Gisele0000950170-24-084666
SEC(opens sec.gov)
Jul 54
Dion Gisele0000950170-23-031855
SEC(opens sec.gov)
Jun 164
Dion Gisele0001209191-23-038078
SEC(opens sec.gov)
Sep 64
Dion Gisele0000899243-22-030439
SEC(opens sec.gov)
Jun 34
Dion Gisele0001209191-22-034259
SEC(opens sec.gov)
Jul 274
Dion Gisele0001209191-21-048387
SEC(opens sec.gov)

Companies

2

Address

C/O CYTEK BIOSCIENCES, INC. 46107 LANDING PARKWAY

FREMONT, CA, 94538